Arthritis News

Patients Taking Cymbalta reg; Reported Reduced Pain Severity Of Osteoarthritis Of The Knee In New Study

Sat, 21 Jun 2008 02:00:04 GMT

New data suggest that patients with osteoarthritis pain of the knee treated with 60 mg and 120 mg Cymbalta (duloxetine HCl) once daily experienced significant pain reduction.

Full text

Actemra Is First Biologic Agent To Show Better Efficacy Than Methotrexate In RA

Wed, 18 Jun 2008 18:40:05 GMT

PARIS: The interleukin-6 receptor inhibitor Actemra (tocilizumab) achieves significantly greater reduction in the signs and symptoms of rheumatoid arthritis (RA) than the current standard of care, methotrexate, according to two international clinical trials reported this week at EULAR 2008, the Annual European Congress of Rheumatology.

Full text

Joint Damage Is Inhibited With Enbrel reg; Etanercept Plus Methotrexate In Patients With Early Active Rheumatoid Arthritis

Wed, 18 Jun 2008 18:40:04 GMT

Data presented recently show that 80% of patients with early active rheumatoid arthritis achieved radiographic remission (or non-progression defined as a change in TSS^a.

Full text

Cimzia reg; Is The First Anti-TNF Shown To Inhibit Progression Of Joint Damage As Early As 16 Weeks In Rheumatoid Arthritis

Wed, 18 Jun 2008 18:40:03 GMT

UCB has announced new data showing that Cimzia (certolizumab pegol), the only PEGylated, Fc-Free anti-TNF (Tumor Necrosis Factor), combined with methotrexate (MTX), significantly inhibits progression of joint damage in patients with active rheumatoid arthritis (RA) as early as 16 weeks after the start of treatment.

Full text

Novel DNA Microarray Chip Predicts Functional Impairment And Remission In Rheumatoid Arthritis

Tue, 17 Jun 2008 15:00:12 GMT

A new DNA microarray chip can predict severe disability and remission in patients with rheumatoid arthritis (RA), as presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Full text

Oily Fish Can Protect Against RA, But Smoking And Psychosocial Stress Increase Its Risk

Tue, 17 Jun 2008 15:00:10 GMT

Results from the EIRA studyNew data presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France, show that intake of oily fish is associated with a reduced risk of developing rheumatoid arthritis (RA), whereas psychosocial work stress and smoking can increase the risk of developing the condition.

Full text

Specific Mutations In The IL2RA Gene Associated With Juvenile Idiopathic Arthritis

Mon, 16 Jun 2008 11:40:08 GMT

Certain single nucleotide polymorphisms (SNPs) within the interleukin 2 receptor alpha (IL2RA) gene region are shown to be associated with juvenile idiopathic arthritis (JIA), according to a new study of two independent cohorts presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Full text

Rheumatoid Arthritis Is A Risk Factor For Cardiovascular Disease

Mon, 16 Jun 2008 11:40:07 GMT

The risk of cardiovascular disease (CVD) for people with rheumatoid arthritis (RA) has been found to be comparable to the risk of CVD in people with type 2 diabetes, according to the conclusions of two studies presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Full text

In Risk Of Severe Cardiovascular Events, Rheumatoid Arthritis Factors Equal To Cardiovascular Factors

Mon, 16 Jun 2008 11:40:05 GMT

Certain cardiovascular disease (CVD) risk factors and rheumatoid arthritis (RA) disease factors have a similar effect on an RA patient's risk of experiencing myocardial infarction (MI) or stroke, according to a new study presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.

Full text

Recommendations For Rheumatoid Arthritis Therapy Presented By American College Of Rheumatology

Sun, 15 Jun 2008 08:20:06 GMT

To manage the painful and incapacitating symptoms of rheumatoid arthritis (RA), a chronic, inflammatory joint disease, the majority of patients rely on disease-modifying antirheumatic drugs (DMARDs).

Full text